Search for: "Green v. Pfizer Inc" Results 1 - 20 of 53
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jan 2010, 10:54 am by Matt C. Bailey
The opinion turns on the trial court’s subsequent decertification of both the UCL and breach of warranty claims based on issues relating to absent class member reliance set forth in the Second District’s decision in Pfizer, Inc. v. [read post]
10 Nov 2021, 4:00 am by Alan Macek
Deeproot Green Infrastructure, LLC v. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
7 Dec 2015, 12:56 pm
Do the “green”, “eco”, “healthy” and “back to basics” movements ring any bell? [read post]
30 Nov 2015, 3:34 am
, pens this post about the well-known and much-debated issue of the product plain packaging [on which see earlier Katposts here, here, here, and here].* Court of Appeal dismisses Rovi's claim construction attempt in battle with VirginA few days ago the Court of Appeal of England and Wales handed down its decision in Rovi Guides Inc v Virgin Media Ltd & Others [2015] EWCA Civ 1214. [read post]
13 Dec 2015, 4:01 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 75 [week ending on Sunday 6 December] –  BHG on blocking injunctions | IP in Universities | Sweden on blocking injunctions | Canadian musings on patents | US Senate and trade secret reform | Chinese IP Courts | G1/14 referral and Article 108 EPC | PACE procedure (Procedure for Accelerated Conduct of Examination) ant the EPO | Greekat and trade mark partenalism | EPO Boards of Appeal tell AC: we were… [read post]
13 Aug 2019, 6:03 am
PepsiCo, Inc. regarding whether use of another’s trademark in a marketing slogan is fair use. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
22 Jan 2009, 2:06 am
Pfizer Inc., 358 F.3d 659, 661 (9th Cir. 2004) (same; physician considered warning inappropriate) (applying California law).Under these facts, if Conte were an ordinary prescription drug product liability case, plaintiff would have been out of court and out of luck, just like Motus. [read post]